Sfoglia per AUTORE
LI S
Collezione AO Ordine Mauriziano
Items : 2
Tislelizumab vs Sorafenib as First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Phase 3 Randomized Clinical Trial. in JAMA oncology / JAMA Oncol. 2023 Dec 1;9(12):1651-1659. doi: 10.1001/jamaoncol.2023.4003.
2023
AO Ordine Mauriziano
AO Ordine Mauriziano
Qin S; Kudo M; Meyer T; Bai Y; Guo Y; Meng Z; Satoh T; Marino D; Assenat E; Li S; Chen Y; Boisserie F; Abdrashitov R; Finn RS; Vogel A; Zhu AX;
Expert consensus on neoadjuvant immunotherapy for non-small cell lung cancer. in Translational lung cancer research / Transl Lung Cancer Res. 2020 Dec;9(6):2696-2715. doi: 10.21037/tlcr-2020-63.
2020
AO Ordine Mauriziano
AO Ordine Mauriziano
Liang W; Cai K; Chen C; Chen H; Chen Q; Fu J; Hu J; Jiang T; Jiao W; Li S; Liu C; Liu D; Liu W; Liu Y; Ma H; Pan X; Qiao G; Tian H; Wei L; Zhang Y; Zhao S; Zhao X; Zhou C; Zhu Y; Zhong R; Li F; Rosell R; Provencio M; Massarelli E; et alii...